Skip to main content
Mehmet Kocoglu, MD, Oncology, Baltimore, MD

MehmetKocogluMD

Oncology Baltimore, MD

Physician

Dr. Kocoglu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kocoglu's full profile

Already have an account?

  • Office

    22 S Greene St
    Baltimore, MD 21201
    Phone+1 410-328-2632
    Fax+1 410-328-6896

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
  • University of Arkansas for Medical Sciences (UAMS) College of Medicine
    University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2003 - 2006
  • University of Arkansas for Medical Sciences (UAMS) College of Medicine
    University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1999 - 1999
  • Hacettepe University FOM
    Hacettepe University FOMClass of 1996

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2014 - 2026
  • CT State Medical License
    CT State Medical License 2010 - 2015
  • AR State Medical License
    AR State Medical License 2006 - 2011

Publications & Presentations

PubMed

Abstracts/Posters

  • Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain Barrier
    Mehmet Hakan Kocoglu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predicti...
    Mehmet Hakan Kocoglu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019